Turkmenistan
Active marketCapital — Ashgabat
Head office and home market. Established relationships with the Ministry of Health and national procurement bodies; full registration, import and tender coverage.
Geography of presence
Five markets. One partner.
SAFIRA PHARMA FZ-LLC operates across Turkmenistan, Kazakhstan, Uzbekistan, Kyrgyzstan and Tajikistan — one team, one contract and an accountable presence in every capital of the region.
The region
Central Asia, seen as one market
Around 80 million people live across our five active markets. Healthcare spend is rising in every one of them: national programmes are modernising hospitals, expanding reimbursement and opening public procurement to international manufacturers. We treat the region as a single, connected opportunity.
- TurkmenistanActive market
- KazakhstanActive market
- UzbekistanActive market
- KyrgyzstanActive market
- TajikistanActive market
- AzerbaijanExpansion market
- MongoliaExpansion market
Markets
Where we operate today
Five active markets with in-country registration, import and tender capability — and two markets where entry is already in preparation.
Kazakhstan
Active marketCapital — Astana
The largest pharmaceutical market of Central Asia, with EAEU regulatory alignment and a mature hospital and retail sector.
Uzbekistan
Active marketCapital — Tashkent
The fastest-growing market of the region — 37 million people, active healthcare reform and expanding public procurement programmes.
Kyrgyzstan
Active marketCapital — Bishkek
EAEU member with streamlined registration pathways; a gateway for regional logistics and cross-border programmes.
Tajikistan
Active marketCapital — Dushanbe
A developing market with strong demand for essential medicines and international donor-funded health programmes.
Azerbaijan
Expansion marketCapital — Baku
Next expansion step across the Caspian — a bridge between Central Asia and the Caucasus.
Mongolia
Expansion marketCapital — Ulaanbaatar
Planned entry with distribution partnerships and registration of the existing portfolio.
Expansion horizon
Beyond the five
The model that works in Central Asia — registration, market access and distribution under one roof — travels well. Azerbaijan and Mongolia are the next confirmed steps. The Caucasus and the Middle East follow as the portfolio and manufacturing partnerships mature.
Azerbaijan
A bridge across the Caspian towards the Caucasus; regulatory groundwork is under way.
Mongolia
Planned entry through distribution partnerships and registration of the existing portfolio.
The Caucasus
Georgia and Armenia as the natural continuation of the Caspian corridor.
Middle East
A longer-term direction, building on our contract-manufacturing relationships.
Market entry
Planning a market entry?
Tell us which markets you are targeting — we will map the registration pathway, timeline and commercial potential for each of them.